Gatifloxacin Activity against Quinolone-Resistant Gyrase: Allele-Specific Enhancement of Bacteriostatic and Bactericidal Activities by the C-8-Methoxy Group
- 1 December 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (12) , 2969-2974
Abstract
Antibacterial activities of gatifloxacin (AM1155), a new C-8-methoxy fluoroquinolone, and two structurally related compounds, AM1121 and ciprofloxacin, were studied with an isogenic set of ten quinolone-resistant, gyrA (gyrase) mutants of Escherichia coli . To compare the effect of each mutation on resistance, the mutant responses were normalized to those of wild-type cells. Alleles exhibiting the most resistance to growth inhibition mapped in α-helix 4, which is thought to lie on a GyrA dimer surface that interacts with DNA. The C-8-methoxy group lowered the resistance due to these mutations more than it lowered resistance arising from several gyrA alleles located outside α-helix 4. These data are consistent with α-helix 4 being a distinct portion of the quinolone-binding site of GyrA. A helix change to proline behaved more like nonhelix alleles, indicating that helix perturbation differs from the other changes at helix residues. Addition of a parC (topoisomerase IV) resistance allele revealed that the C-8-methoxy group also facilitated attack of topoisomerase IV. When lethal effects were measured at a constant multiple of the minimum inhibitory concentration for each fluoroquinolone to normalize for differences in bacteriostatic action, gatifloxacin was more potent than the C-8-H compounds, both in the presence and absence of protein synthesis (an exception was observed when alanine was substituted for aspartic acid at position 82). Collectively, these data show that the C-8-methoxy group contributes to the enhanced activity of gatifloxacin against resistant gyrase and wild-type topoisomerase IV.Keywords
This publication has 26 references indexed in Scilit:
- Conformational Changes in DNA Gyrase Revealed by Limited ProteolysisJournal of Biological Chemistry, 1998
- The DNA Gyrase-Quinolone ComplexJournal of Biological Chemistry, 1998
- Mechanisms of Quinolone resistanceJournal of Infection and Chemotherapy, 1997
- DNA Gyrase and Topoisomerase IV on the Bacterial Chromosome: Quinolone-induced DNA CleavageJournal of Molecular Biology, 1996
- Topoisomerase IV is a target of quinolones in Escherichia coli.Proceedings of the National Academy of Sciences, 1995
- DNA supercoiling in a thermotolerant mutant ofEscherichia coliMolecular Genetics and Genomics, 1995
- Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Improved bactericidal activity of Q-35 against quinolone-resistant staphylococciAntimicrobial Agents and Chemotherapy, 1995
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990
- Mutations in the gene coding for Escherichia coli DNA topoisomerase I affect transcription and transposition.Proceedings of the National Academy of Sciences, 1981